Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer

被引：0
|
作者：
Takehiro Hirai
Asuka Nemoto
Yoshinori Ito
Masaaki Matsuura
机构：
[1] Teikyo University Graduate School of Public Health,Clinical Development Department
[2] Daiichi Sankyo RD Novare Co.,Breast Medical Oncology, Breast Oncology Center
[3] Ltd.,Division of Cancer Genomics
[4] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,undefined
[5] The Cancer Institute,undefined
[6] Japanese Foundation for Cancer Research,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 181卷
关键词：
Triple-negative breast cancer; Overall survival; Progression-free survival; Meta-analysis; Surrogate endpoint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：189 / 198
页数：9
相关论文
共 50 条
  • [41] Progression-free survival is a surrogate for survival in advanced colorectal cancer
    Buyse, Marc
    Burzykowski, Tomasz
    Carroll, Kevin
    Michiels, Stefan
    Sargent, Daniel J.
    Miller, Langdon L.
    Elfring, Gary L.
    Pignon, Jean-Pierre
    Piedbois, Pascal
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5218 - 5224
  • [42] Evaluation of event-free survival as a surrogate for overall survival in early-stage triple-negative breast cancer following neoadjuvant therapy
    Fasching, P. A.
    Huang, M.
    Haiderali, A.
    Xue, W.
    Pan, W.
    Karantza, V.
    Yang, F.
    Truscott, J.
    Xin, Y.
    O'Shaughnessy, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S621 - S621
  • [43] Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2- metastatic breast cancer
    Forsythe, Anna
    Chandiwana, David
    Barth, Janina
    Thabane, Marroon
    Baeck, Johan
    Tremblay, Gabriel
    BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 69 - 78
  • [44] IN ADVANCED/METASTATIC BREAST CANCER, IS PROGRESSION-FREE SURVIVAL A SURROGATE OUTCOME?
    Franca, A. C.
    Schroeder, L.
    Padilla, M.
    Meirelles, I
    Silva, A. S.
    Magliano, C.
    Santos, M.
    VALUE IN HEALTH, 2020, 23 : S477 - S478
  • [45] Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
    Trippa, Lorenzo
    Wen, Patrick Y.
    Parmigiani, Giovanni
    Berry, Donald A.
    Alexander, Brian M.
    NEURO-ONCOLOGY, 2015, 17 (08) : 1106 - 1113
  • [46] Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
    Yin, Jianyun
    Zhu, Changtai
    Wang, Gaofeng
    Gu, Jianwei
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 5901 - 5914
  • [47] Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
    Liu, Liya
    Yu, Hao
    Huang, Lihong
    Shao, Fang
    Bai, Jianling
    Lou, Donghua
    Chen, Feng
    OncoTargets and Therapy, 2015, 8 : 921 - 928
  • [48] Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation
    Fabregat Franco, Carles
    Castet, Florian
    La Casta, Adelaida
    Adeva, Jorge
    Castillo, Alfredo
    Munoz, Andres
    Peinado, Paloma
    Martinez de Castro, Eva
    Lobo, Miriam
    Granja, Monica
    Maria Rodriguez-Alonso, Rosa
    Fernandez Montes, Ana
    Vera, Ruth
    Gallego, Javier
    Grana, Begona
    Ghanem, Ismael
    Ales, Inmaculada
    Molina, Raquel
    Macarulla, Teresa
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Histologic subtypes in chemotherapy vs. sacituzumab sovitecan groups might affect progression-free and overall survival in metastatic triple-negative breast cancer
    Altundag, Kadri
    JOURNAL OF BUON, 2021, 26 (03): : 1174 - 1175
  • [50] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
12345